RAPPORT THERAPEUTICS INC (RAPP) Stock Income Statement
NASDAQ:RAPP - Nasdaq - US75383L1026 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 94.00M | 83.00M | 36.00M | 10.37M | |||
| Research and Development | N/A | 60.94M | 28.00M | 9.12M | |||
| Selling, General, and Administrative Expenses | 25.07M | 22.00M | 8.18M | 1.25M | |||
| Operating Income | -94.00M | -83.00M | -36.00M | -10.37M | |||
| Interest Income/Expense | N/A | 12.14M | 2.53M | -285.00K | |||
| Other Income/Expense | 3.00M | -7.39M | -1.12M | N/A | |||
| Income Before Taxes | -80.00M | -78.00M | -35.00M | -10.65M | |||
| Income Tax | 0.00 | 0.00 | 10.00K | N/A | |||
| Net Income | -80.00M | -78.00M | -35.00M | -10.65M | |||
| EBITDA | -93.07M | -82.16M | -35.89M | -10.35M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.25 | -3.71 | -1.00 | -0.30 | |||
| Non GAAP EPS | -3.45 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD